BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31950769)

  • 21. The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults.
    Nanna MG; Peterson ED; Wojdyla D; Navar AM
    J Gen Intern Med; 2020 Jun; 35(6):1701-1708. PubMed ID: 31667745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.
    Tang X; Zhang D; He L; Wu N; Si Y; Cao Y; Huang S; Li N; Li J; Dou H; Gao P; Hu Y
    Am Heart J; 2019 May; 211():34-44. PubMed ID: 30831332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining European and U.S. risk prediction models with polygenic risk scores to refine cardiovascular prevention: the CoLaus|PsyCoLaus Study.
    de La Harpe R; Thorball CW; Redin C; Fournier S; Müller O; Strambo D; Michel P; Vollenweider P; Marques-Vidal P; Fellay J; Vaucher J
    Eur J Prev Cardiol; 2023 May; 30(7):561-571. PubMed ID: 36652418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
    Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
    J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Blood Heavy Metal Levels and Predicted 10-Year Risk for A First Atherosclerosis Cardiovascular Disease in the General Korean Population.
    Choi S; Kwon J; Kwon P; Lee C; Jang SI
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32210108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the performance of machine learning and conventional models for predicting atherosclerotic cardiovascular disease in a general Chinese population.
    Fan Z; Du Z; Fu J; Zhou Y; Zhang P; Shi C; Sun Y
    BMC Med Inform Decis Mak; 2023 Jul; 23(1):134. PubMed ID: 37488520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).
    Yang X; Li J; Hu D; Chen J; Li Y; Huang J; Liu X; Liu F; Cao J; Shen C; Yu L; Lu F; Wu X; Zhao L; Wu X; Gu D
    Circulation; 2016 Nov; 134(19):1430-1440. PubMed ID: 27682885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing Level of Agreement for Atherosclerotic Cardiovascular Disease Risk Categorization Between Coronary Artery Calcium Score and the American College of Cardiology/American Heart Association Cardiovascular Prevention Guidelines and the Potential Impact on Treatment Recommendations.
    Isma'eel H; Min D; Al-Shaar L; Hachamovitch R; Halliburton S; Gentry J; Griffin B; Schoenhagen P; Phelan D
    Am J Cardiol; 2016 Nov; 118(10):1480-1485. PubMed ID: 27642113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection.
    Triant VA; Perez J; Regan S; Massaro JM; Meigs JB; Grinspoon SK; D'Agostino RB
    Circulation; 2018 May; 137(21):2203-2214. PubMed ID: 29444987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the general Framingham Risk Score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population.
    Kasim SS; Ibrahim N; Malek S; Ibrahim KS; Aziz MF; Song C; Chia YC; Ramli AS; Negishi K; Mat Nasir N
    Lancet Reg Health West Pac; 2023 Jun; 35():100742. PubMed ID: 37424687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of validation and application on various cardiovascular disease mortality risk prediction models in Chinese rural population.
    Sun C; Xu F; Liu X; Fang M; Zhou H; Lian Y; Xie C; Sun N; Wang C
    Sci Rep; 2017 Mar; 7():43227. PubMed ID: 28337999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study.
    Henderson K; Kaufman B; Rotter JS; Stearns S; Sueta CAA; Foraker R; Ho PM; Chang PP
    BMJ Open; 2022 Nov; 12(11):e058777. PubMed ID: 36343998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study.
    Al-Shamsi S; Govender RD; King J
    BMJ Open; 2020 Oct; 10(10):e040680. PubMed ID: 33115904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of Traditional Risk Factors to Adequately Predict Cardiovascular Events in Older Populations.
    Dalton JE; Rothberg MB; Dawson NV; Krieger NI; Zidar DA; Perzynski AT
    J Am Geriatr Soc; 2020 Apr; 68(4):754-761. PubMed ID: 31958154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification.
    Ghosh AK; Venkatraman S; Nanna MG; Safford MM; Colantonio LD; Brown TM; Pinheiro LC; Peterson ED; Navar AM; Sterling MR; Soroka O; Nahid M; Banerjee S; Goyal P
    JAMA Cardiol; 2024 Jan; 9(1):55-62. PubMed ID: 38055247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study.
    Polter EJ; Blaes A; Wolfson J; Lutsey PL; Florido R; Joshu CE; Guha A; Platz EA; Prizment A
    J Cancer Surviv; 2024 Feb; 18(1):124-134. PubMed ID: 37140677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical risk markers and 10-year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification.
    Akintoye E; Briasoulis A; Afonso L
    Am Heart J; 2017 Nov; 193():95-103. PubMed ID: 29129262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.
    Chen S; Li N; Shen Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):966-973. PubMed ID: 34707006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.